Symbols

TLSI

TriSalus Life·NASDAQ

--(--)

TLSI Profile

Trisalus Life Sciences, Inc.

An immunotherapy company that develops and commercialises therapies using a three-pronged therapeutic approach combining immunomodulation therapy, tumour-killing agents, and a proprietary intravascular regional delivery technology for the treatment of liver and pancreatic tumours

Industry

Life Science Tools and Services

Established Date

Listing Date

02/08/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

102

Fiscal Year Ends

12-31

Website

www.trisaluslifesci.com

Security Type

Common stock

Office address

6272 W. 91st Ave. , Westminster, CO 80031

Business

Introduction

TriSalus Life Sciences, Inc., was incorporated in Delaware in September 2020. The company is an oncology-focused medical technology company that combines its stress-enhancing drug delivery technology with standard therapies and an investigational immunotherapy drug designed to improve the prognosis of patients with solid tumors. Its FDA-approved TriNav infusion system is designed to enhance the delivery of endovascular therapeutic drugs by regulating intravascular pressure and flow.